Rotavirus Vaccines Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
Rotavirus, as the name suggests, is a kind of virus that readily infects children and infants. The virus can cause severe watery diarrhea, fever, vomiting, and abdominal pain. Rotavirus-infected children usually suffer from dehydration and in severe cases, they need to be hospitalized. Rotavirus vaccine is a highly successful method to protect children from rotavirus infection. Before the introduction of rotavirus vaccines in the market, rotavirus disease was a serious health issue among children in major developed and developing countries. For instance, in the U.S., almost all children have at least one rotavirus infection within the span of five years from birth; around 400,000 children are taken to doctors for treatment; and around 50–60 deaths occur every year. However, after the introduction of rotavirus vaccines, the number of emergency visits and hospitalizations due to rotavirus infection has dropped significantly. Four out of five children that are vaccinated get protection from severe rotavirus infection.
The global rotavirus vaccines market can be segmented based on product and distribution channel. Among products, two vaccines are licensed for use in the U.S. viz. RotaTeq (RV5) and Rotarix (RV1). RotaTeq is administered in three doses and Rotarix is administered in two doses at the interval of every two months. The first dose in administered after two months of birth. Currently, two key players operate in the rotavirus vaccines market, which are WHO-prequalified: Merck and GlaxoSmithKline (GSK). Two rotavirus vaccines currently being developed are expected to gain pre-qualification from the WHO between 2017 and 2018. One of these is Rotavac, which is being manufactured by Bharat Biotech. It was licensed for use in India in 2014. Based on distribution channel, the global rotavirus vaccines market can be classified into hospitals, pharmacies, and clinics / health care centers associated with government programs. The inflow of patients to hospitals is expected to increase during the forecast period, as hospitals are considered to be more reliable and they have a large number of suppliers, reimbursement authority, and government support.
Increasing incidence of rotavirus infection among children is a major factor that drives the market, as it leads to the rise in demand for rotavirus vaccines. Rotavirus disease is highly contagious and it spreads easily among children due to their poor hygiene habits. The spread of rotavirus infection is a common issue in hospitals and daycare settings. Along with this, support from organizations such as UNICEF and GAVI (is a vaccine alliance of multiple countries under which 45 countries are approved for Rotavirus vaccine support) for large scale vaccination, supply availability, and access to affordable prices is another factor fueling the rotavirus vaccines market. There are a few restrictions in delivering the rotavirus vaccines. For instance, a baby or infant who had a history of allergic reaction upon the administration of rotavirus vaccine should not be administered another dose. Also, diarrhea or vomiting caused by any other microorganism should not be treated with rotavirus vaccines. A virus named porcine circovirus is found in both rotavirus vaccines. Even though porcine circovirus does not have any harmful effect and there is no known safety risk, it is not preferred for critical patients. Moreover, delayed timelines for new manufacturers, delays in planned introductions, rising demand that exceeds the current supply, and uncertain demand from non-GAVI MICs are other factors that restrict the market for rotavirus vaccines.
Based on geography, the global rotavirus vaccines market has been divided into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global rotavirus vaccines market, with the U.S. accounting for a major market share. Manufacturers in the Americas are developing innovative products to cure severe rotavirus infections among children. The safety and efficacy of these new products are being ensured by pre-market approval through clinical trials. Europe is considered the second-largest market for rotavirus vaccines. On the other hand, the market in Asia Pacific is expected to expand rapidly and at the maximum growth rate during the forecast period. This is attributable to rising government initiatives and favorable government laws in the region. Also, major manufacturers with their rotavirus vaccines currently undergoing development are located in Asia Pacific. For instance, Bharat Biotech International Limited, a manufacturer of Rotavac, is located in India and Lanzhou Institute of Biological Products that manufactures Lanzhou lamb rotavirus vaccine is located in China. Emerging countries with rapidly developing economies offer significant growth opportunities to the rotavirus vaccines market, as they witness the rising prevalence of rotavirus infection.
Key players in the global rotavirus vaccines market are GlaxoSmithKline (GSK), Merck, and Bharat Biotech International Limited. Other prominent bodies that are working on the development of rotavirus vaccines are Center for Research and Production of Vaccines, Vietnam and Lanzhou Institute of Biological Products, China.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Vaccines
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017